STAT

MARCH 18, 2024

The biggest enticement that large pharmacy benefit managers offer to the employers that hire them is drug rebates — a steady stream of money sent back to their clients, a tangible symbol of the discounts that PBMs are able to wrangle out of pharmaceutical companies. PBMs, the middlemen of drug pricing negotiations, also claim portions of those lucrative rebates for themselves.

Biosimilars 363

Biosimilars Drug Pricing Documentation Pharmaceutical Companies 363

ALiEM - Pharm Pearls

MARCH 18, 2024

A 30-year-old female with a past medical history of Crohn’s Disease presented to the ED for evaluation of an acutely bruised right 4th finger. She stated she was typing on a computer keyboard approximately 10 minutes prior to presentation and she noticed a sudden popping sensation at the base of her right ring finger. After the popping sensation, she noticed a cool sensation of the finger and numbness to the entire finger.

303

303

STAT

MARCH 18, 2024

I was recently working with a young mother who struggled with depression and anxiety in the difficult year following the birth of her child. In addition to managing the herculean task of adjusting to motherhood, she had trouble coping with her baby’s complex medical needs. While I explained to her the importance of tending to her mental health and the connection between parental well-being and healthy child development, she burst out crying.

350

350

PharmaVoice

MARCH 18, 2024

Aily Labs’ tech makes predictive business decisions for life science companies and comes from a need its founder witnessed in Big Pharma.

148

148

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

STAT

MARCH 18, 2024

The Food and Drug Administration on Monday approved a gene therapy for metachromatic leukodystrophy, a devastating genetic disorder that eats away at affected children’s neurons. The medicine, marketed as Lenmeldy, is the first treatment for MLD, which is otherwise fatal. Lenmeldy has to be given before symptoms appear or, in some cases, after the first signs of disease, so it won’t be helpful for many patients living with MLD today.

332

332

The Pharmacist

MARCH 18, 2024

The number of pharmacists working in general practices and primary care networks in England increased by 24.5% between December 2022 and December 2023, quarterly statistics from NHS Digital have revealed. And the number of pharmacy technicians working in general practice and PCNs in England has risen by over 40% since December 2022, the statistics reported […] The post Number of practice pharmacists up 25% in a year appeared first on The Pharmacist.

Pharmacy Technician 122

Pharmacy Technician 122

The Pharmacist

MARCH 18, 2024

The Pharmacists’ Defence Association (PDA) has highlighted the need for pharmacy contractors to provide adequate personal protective equipment (PPE) to pharmacists and their teams to guard against Covid-19, shingles and other viruses. According to the PDA, health and safety issues have been raised by members regarding protection from infection, with some concerned that adequate PPE […] The post Infection concerns prompt call for adequate PPE for pharmacy teams appeared first on The Pharmac

120

120

STAT

MARCH 18, 2024

I was wrong about Geron. For years, I’ve believed — and declared publicly — that Geron’s effort to develop a blood cancer drug called imetelstat would end in disappointment. The drug was never getting approved , I said. On Thursday, a group of outside experts convened by the Food and Drug Administration voted 12-2 in imetelstat’s favor, concluding the drug’s benefits outweighed its risks for the treatment of patients with myelodysplastic syndrome.

260

260

Putting Patients First Blog

MARCH 18, 2024

Guest Blog: Kidney Month Marks 31 Days of Action to Equip and Empower People to Prioritize their Kidney Health and Fight Kidney Disease March 18, 2024 LaVarne A. Burton, President and CEO, American Kidney Fund March is Kidney Month , a month in which the American Kidney Fund (AKF) marks 31 days of action that are focused on equipping and empowering people with the tools and knowledge they need to prioritize their kidney health and fight kidney disease.

Diabetes 122

Diabetes 122

STAT

MARCH 18, 2024

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Today we ponder the vast open spaces of Boston’s unused life sciences labs, see a new biopharma IPO in the works, and expect a label expansion for some CAR-T blood cancer therapies.

Labelling 212

Labelling Drug Pricing Drug Development 212

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

PharmaVoice

MARCH 18, 2024

Pharma’s recent wins have led to pay windfalls for several company leaders.

130

130

STAT

MARCH 18, 2024

WASHINGTON — The Environmental Protection Agency on Monday announced a comprehensive ban on asbestos , a carcinogen that is still used in some chlorine bleach, brake pads and other products and that kills tens of thousands of Americans every year. The final rule marks a major expansion of EPA regulation under  a landmark 2016 law  that overhauled regulations governing tens of thousands of toxic chemicals in everyday products, from household cleaners to clothing and furniture.

200

200

pharmaphorum

MARCH 18, 2024

Discover the top 7 challenges faced by pharmaceutical and life sciences companies in achieving patient-centricity and engaging healthcare professionals (HCPs). Explore strategies to overcome these obstacles for successful outreach efforts.

109

109

STAT

MARCH 18, 2024

Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and inspiring, because that oh-so familiar routine of online meetings, phone calls, and deadlines has returned. You knew this would happen, yes? After all, the world, such as it is, continues to spin. So time to give it a nudge in a better direction with a cup of stimulation.

189

189

Pharmaceutical Technology

MARCH 18, 2024

Akums Drugs and Pharmaceuticals has introduced Hydroxyurea oral suspension, a room temperature-stable drug for treating sickle cell disease.

122

122

pharmaphorum

MARCH 18, 2024

FDA advisors have said that two BCMA-targeted CAR-T therapies can be used earlier in the treatment pathway for multiple myeloma, setting up FDA approvals for use in a broader patient population.

107

107

Pharmaceutical Commerce

MARCH 18, 2024

In this Pharmaceutical Commerce video interview, Joerg Tritschler, a partner in Simon-Kucher’s life sciences division, discusses the positive signs from rising activity levels in biopharma M&A— and what the momentum may mean for industry dealmaking and partnership efforts in the months ahead.

105

105

European Pharmaceutical Review

MARCH 18, 2024

A study has determined that intermittent low-intensity far-UVC light can inhibit mould growth below the threshold limit value of 23 mJ/cm 2. At 222nm, far-UVC light was shown to prevent development of common mould-producing fungi , specifically Penicillium candidum. The on-off duty cycle pattern of the far-UVC light used in the study is “consistent with its use in real-world settings”, the corresponding paper stated.

98

98

BioPharma Dive

MARCH 18, 2024

Balancing automated patient support with human touch is key in healthcare. Hybrid models offer a pragmatic path forward, prioritizing patient-centricity.

102

102

pharmaphorum

MARCH 18, 2024

Agreement has been reached in the EU on a European Health Data Space (EHDS), which will make it easier to exchange and access electronic health data.

103

103

Express Pharma

MARCH 18, 2024

Lupin has appointed Christoph Funke to the newly-created position of Chief Technical Operations Officer. Funke has over 30 years of global pharma manufacturing, supply chain, and technical operations experience. He will be based in Mumbai and will oversee Lupin’s Technical Operations function, integrating manufacturing, supply chain, and procurement.

94

94

pharmaphorum

MARCH 18, 2024

The PM Society’s 38th annual awards were held last week, on Friday 15th March, at the JW Marriott Grosvenor House London, at which over 900 industry professionals came together to celebrate the best in creative, impactful, and innovative communications in pharma and healthcare.

Communication 92

Communication 92

Express Pharma

MARCH 18, 2024

In today’s pharma industry, “sustainable pharmaceuticals” refers to practices that prioritise minimising environmental impact while promoting public health and social responsibility. This includes eco-friendly manufacturing, waste reduction, and responsible disposal. It underscores the need for companies to balance profitability with environmental and social concerns, aiming for a healthier, more sustainable future.

Packaging 94

Packaging 94

European Pharmaceutical Review

MARCH 18, 2024

A Phase III trial has shown that compared oral drug delivery, administering levodopa through an infusion pump led to nearly two hours of day (1.72) of additional time in which the medicine reduced symptoms in Parkinson’s patients. There were 381 Parkinson’s patients enrolled in the trial. Levodopa was delivered for 24 hours via a subcutaneous infusion pump, which was shown to be a safe method of drug delivery, the research found.

91

91

Express Pharma

MARCH 18, 2024

Sun Pharmaceutical Industries announced that the Australian Therapeutic Goods Administration (TGA) has granted regulatory approval for Winlevi (clascoterone cream 1%). Winlevi is indicated for the topical treatment of acne vulgaris in patients 12 years of age and older. Hellen de Kloet, Business Head – Western Europe, Australia and New Zealand, Sun Pharma said, “Winlevi is an exciting addition to our expanding dermatology portfolio of innovative medicines in Australia.

93

93

pharmaphorum

MARCH 18, 2024

AI software designed to tackle missed appointments and reduce waiting lists will see its use by NHS England ramp up after a successful pilot deployment.

98

98

Outsourcing Pharma

MARCH 18, 2024

In an encouraging development, neuromodulation, a form of bioelectric medicine, has emerged as a promising avenue for enhancing health by regulating the nervous system.

87

87

pharmaphorum

MARCH 18, 2024

Bristol-Myers Squibb gets its $14bn takeover of Karuna Therapeutics over the finish line, taking control of schizophrenia candidate KarXT ahead of an FDA decision in September

86

86

Outsourcing Pharma

MARCH 18, 2024

In a significant move aimed at supporting patients battling amyotrophic lateral sclerosis (ALS), myTomorrows has announced a strategic partnership with the ALS Association, a leading nonprofit organization dedicated to combating ALS.

80

80

Pharma Times

MARCH 18, 2024

Up to 20% of prostate cancer cases are classified as castration-resistant

120

120

Outsourcing Pharma

MARCH 18, 2024

The curtains have risen on DCAT 2024 in the vibran heart of New York City, and leading pharmaceutical companies from around the world have converged for a week of innovation, collaboration, and strategic dialogue.

Pharmaceutical Companies 78

Pharmaceutical Companies Pharmaceutical Companies 78

Pharmaceutical Technology

MARCH 18, 2024

The US FDA's ODAC has recommended Johnson & Johnson’s CARVYKTI to treat relapsed or refractory multiple myeloma (R/R MM).

95

95

Drug Channels

MARCH 18, 2024

Informa Connect’s Life Sciences Pricing & Contracting USA May 21-23, 2024 | New Orleans Drug Channels readers save 10% with code 24DRCH10* Whether your daily focus is on Medicaid, Government Pricing, 340B, Drug Price Transparency, Commercial Contracting or Chargebacks , we have you covered! Informa Connect is thrilled to announce Pricing & Contracting USA , an innovative summit that brings together three of the life science industry’s most well-known events (Medicaid & Government Pri

Drug Pricing 76

Drug Pricing 76

Pharma Times

MARCH 18, 2024

The centre will deliver free training, outreach materials and programmes

Vaccines 110

Vaccines 110

BioPharma Dive

MARCH 18, 2024

HCPs today want inbound channels for help when they need it. See how you can meet their preferences.

102

102